Peter Webster serves as Associate Director of Analytical Science & Technology at Solid Biosciences Inc., where he provides leadership for analytical strategies supporting the development of gene therapy products. With a background in analytical development, he has led efforts in assay development, method validation, product characterization, and comparability testing for advanced therapies. Peter's expertise includes the application of analytical control strategies to support clinical and commercial manufacturing, regulatory submissions, and lifecycle management activities. He is passionate about advancing innovative analytical approaches that enable the efficient development and commercialization of transformative genetic medicines.